OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients
Briegeen Girvin, GD Johnston
Journal of Hypertension (1998) Vol. 16, Iss. 7, pp. 1049-1054
Closed Access | Times Cited: 24
Briegeen Girvin, GD Johnston
Journal of Hypertension (1998) Vol. 16, Iss. 7, pp. 1049-1054
Closed Access | Times Cited: 24
Showing 24 citing articles:
Dosing Frequency and Medication Adherence in Chronic Disease
Craig I Coleman, Brendan Limone, Diana M Sobieraj, et al.
Journal of Managed Care Pharmacy (2012) Vol. 18, Iss. 7, pp. 527-539
Open Access | Times Cited: 392
Craig I Coleman, Brendan Limone, Diana M Sobieraj, et al.
Journal of Managed Care Pharmacy (2012) Vol. 18, Iss. 7, pp. 527-539
Open Access | Times Cited: 392
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
Morris J. Brown, Bryan Williams, S. V. Morant, et al.
The Lancet Diabetes & Endocrinology (2015) Vol. 4, Iss. 2, pp. 136-147
Open Access | Times Cited: 123
Morris J. Brown, Bryan Williams, S. V. Morant, et al.
The Lancet Diabetes & Endocrinology (2015) Vol. 4, Iss. 2, pp. 136-147
Open Access | Times Cited: 123
Effect of dosing frequency on chronic cardiovascular disease medication adherence
Craig I Coleman, Matthew Roberts, Diana M Sobieraj, et al.
Current Medical Research and Opinion (2012) Vol. 28, Iss. 5, pp. 669-680
Closed Access | Times Cited: 121
Craig I Coleman, Matthew Roberts, Diana M Sobieraj, et al.
Current Medical Research and Opinion (2012) Vol. 28, Iss. 5, pp. 669-680
Closed Access | Times Cited: 121
Cardiovascular Drugs and Serum Uric Acid
Ariel J. Reyes
Cardiovascular Drugs and Therapy (2003) Vol. 17, Iss. 5/6, pp. 397-414
Closed Access | Times Cited: 158
Ariel J. Reyes
Cardiovascular Drugs and Therapy (2003) Vol. 17, Iss. 5/6, pp. 397-414
Closed Access | Times Cited: 158
The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio
Susan J. Hood, Kevin Taylor, Michael J. Ashby, et al.
Circulation (2007) Vol. 116, Iss. 3, pp. 268-275
Open Access | Times Cited: 102
Susan J. Hood, Kevin Taylor, Michael J. Ashby, et al.
Circulation (2007) Vol. 116, Iss. 3, pp. 268-275
Open Access | Times Cited: 102
Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis
Erin R. Weeda, Craig I Coleman, Colleen A. McHorney, et al.
International Journal of Cardiology (2016) Vol. 216, pp. 104-109
Closed Access | Times Cited: 67
Erin R. Weeda, Craig I Coleman, Colleen A. McHorney, et al.
International Journal of Cardiology (2016) Vol. 216, pp. 104-109
Closed Access | Times Cited: 67
Renin: friend or foe?
M. J Brown
Heart (2007) Vol. 93, Iss. 9, pp. 1026-1033
Open Access | Times Cited: 83
M. J Brown
Heart (2007) Vol. 93, Iss. 9, pp. 1026-1033
Open Access | Times Cited: 83
Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review
Arne Christensen, Lars Osterberg, Ebba Holme Hansen
Journal of Hypertension (2009) Vol. 27, Iss. 8, pp. 1540-1551
Closed Access | Times Cited: 81
Arne Christensen, Lars Osterberg, Ebba Holme Hansen
Journal of Hypertension (2009) Vol. 27, Iss. 8, pp. 1540-1551
Closed Access | Times Cited: 81
White coat effect, blood pressure and mortality in men: prospective cohort study
Timo Strandberg
European Heart Journal (2000) Vol. 21, Iss. 20, pp. 1714-1718
Open Access | Times Cited: 92
Timo Strandberg
European Heart Journal (2000) Vol. 21, Iss. 20, pp. 1714-1718
Open Access | Times Cited: 92
Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia
Sirirat Reungjui, Thongchai Pratipanawatr, Richard J. Johnson, et al.
Current Opinion in Nephrology & Hypertension (2008) Vol. 17, Iss. 5, pp. 470-476
Open Access | Times Cited: 61
Sirirat Reungjui, Thongchai Pratipanawatr, Richard J. Johnson, et al.
Current Opinion in Nephrology & Hypertension (2008) Vol. 17, Iss. 5, pp. 470-476
Open Access | Times Cited: 61
The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure
Ariel J. Reyes
European Journal of Heart Failure (2005) Vol. 7, Iss. 4, pp. 461-467
Open Access | Times Cited: 58
Ariel J. Reyes
European Journal of Heart Failure (2005) Vol. 7, Iss. 4, pp. 461-467
Open Access | Times Cited: 58
Diuretics in cardiovascular therapy: the new clinicopharmacological bases that matter.
Ariel J. Reyes, Stanley H. Taylor
Cardiovascular Drugs and Therapy (1999) Vol. 13, Iss. 5, pp. 371-398
Closed Access | Times Cited: 33
Ariel J. Reyes, Stanley H. Taylor
Cardiovascular Drugs and Therapy (1999) Vol. 13, Iss. 5, pp. 371-398
Closed Access | Times Cited: 33
Diuretics in the therapy of hypertension
Ariel J. Reyes
Journal of Human Hypertension (2002) Vol. 16, Iss. S1, pp. S78-S83
Open Access | Times Cited: 30
Ariel J. Reyes
Journal of Human Hypertension (2002) Vol. 16, Iss. S1, pp. S78-S83
Open Access | Times Cited: 30
The aldosterone antagonist and facultative diuretic eplerenone: a critical review
Ariel J. Reyes, W P Leary, Giuseppe Crippa, et al.
European Journal of Internal Medicine (2005) Vol. 16, Iss. 1, pp. 3-11
Closed Access | Times Cited: 23
Ariel J. Reyes, W P Leary, Giuseppe Crippa, et al.
European Journal of Internal Medicine (2005) Vol. 16, Iss. 1, pp. 3-11
Closed Access | Times Cited: 23
The increase in serum uric acid induced by diuretics could be beneficial to cardiovascular prognosis in hypertension
Ariel J. Reyes, W P Leary
Journal of Hypertension (2003) Vol. 21, Iss. 9, pp. 1775-1777
Closed Access | Times Cited: 21
Ariel J. Reyes, W P Leary
Journal of Hypertension (2003) Vol. 21, Iss. 9, pp. 1775-1777
Closed Access | Times Cited: 21
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension
Morris J. Brown, Bryan Williams, Thomas M. MacDonald, et al.
BMJ Open (2015) Vol. 5, Iss. 8, pp. e008086-e008086
Open Access | Times Cited: 9
Morris J. Brown, Bryan Williams, Thomas M. MacDonald, et al.
BMJ Open (2015) Vol. 5, Iss. 8, pp. e008086-e008086
Open Access | Times Cited: 9
The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid?
Ariel J. Reyes, W P Leary
Cardiovascular Drugs and Therapy (2002) Vol. 16, Iss. 6, pp. 485-487
Closed Access | Times Cited: 15
Ariel J. Reyes, W P Leary
Cardiovascular Drugs and Therapy (2002) Vol. 16, Iss. 6, pp. 485-487
Closed Access | Times Cited: 15
Alternate-Day Dosing of HMG-CoA Reductase Inhibitors for Cholesterol Reduction
Charity A Metz, Kristy H. Lucas
Annals of Pharmacotherapy (2001) Vol. 35, Iss. 4, pp. 496-500
Closed Access | Times Cited: 14
Charity A Metz, Kristy H. Lucas
Annals of Pharmacotherapy (2001) Vol. 35, Iss. 4, pp. 496-500
Closed Access | Times Cited: 14
The choice of diuretic in hypertension: saving the baby from the bathwater
M. J. Brown
Heart (2011) Vol. 97, Iss. 19, pp. 1547-1551
Closed Access | Times Cited: 7
M. J. Brown
Heart (2011) Vol. 97, Iss. 19, pp. 1547-1551
Closed Access | Times Cited: 7
Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure
John E. Scoble
Journal of the Royal Society of Medicine (1999) Vol. 92, Iss. 10, pp. 505-510
Open Access | Times Cited: 9
John E. Scoble
Journal of the Royal Society of Medicine (1999) Vol. 92, Iss. 10, pp. 505-510
Open Access | Times Cited: 9
Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25???mg/day or 2.5???mg/day and Potassium Chloride Compared with Enalapril 10???mg/day and Amlodipine 5???mg/day in Patients with Mild to Moderate Primary Hypertension
Sten Rasmussen, N. J. Borrild, Jeffrey Andersen
Clinical Drug Investigation (2006) Vol. 26, Iss. 2, pp. 91-101
Closed Access | Times Cited: 5
Sten Rasmussen, N. J. Borrild, Jeffrey Andersen
Clinical Drug Investigation (2006) Vol. 26, Iss. 2, pp. 91-101
Closed Access | Times Cited: 5
The aldosterone antagonist and facultative diuretic eplerenone: A critical review
Ariel J. Reyes, W P Leary, Giuseppe Crippa, et al.
European Journal of Internal Medicine (2005) Vol. 16, Iss. 3, pp. 145-153
Closed Access | Times Cited: 4
Ariel J. Reyes, W P Leary, Giuseppe Crippa, et al.
European Journal of Internal Medicine (2005) Vol. 16, Iss. 3, pp. 145-153
Closed Access | Times Cited: 4
Aliskiren in an alternate-day administration schedule in hypertensive albuminuric patients
Georgios Spanos, Rigas Kalaitzidis, Despina Karasavvidou, et al.
Blood Pressure Monitoring (2014) Vol. 19, Iss. 6, pp. 359-365
Closed Access | Times Cited: 2
Georgios Spanos, Rigas Kalaitzidis, Despina Karasavvidou, et al.
Blood Pressure Monitoring (2014) Vol. 19, Iss. 6, pp. 359-365
Closed Access | Times Cited: 2
